[1]
Susanah, S., Widowati, W., Sari, N.M., Revika, R., Kusuma, H., Rizal, R. and Faried, A. 2022. Potential Use of Patient-Specific Induced Pluripotent Stem Cell for Liver Fibrosis Thalassemia Treatment Management. Open Access Macedonian Journal of Medical Sciences. 10, F (Feb. 2022), 122–128. DOI:https://doi.org/10.3889/oamjms.2022.8326.